In the BioHarmony Drug Report Database

"Preview" Icon

Velmanase alfa

Lamzede (velmanase alfa) is an enzyme pharmaceutical. Velmanase alfa was first approved as Lamzede on 2018-03-23. It has been approved in Europe to treat alpha-mannosidosis.

 

Trade Name

 

Lamzede
 

Common Name

 

velmanase alfa
 

ChEMBL ID

 

CHEMBL4298010
 

Indication

 

alpha-mannosidosis
 

Drug Class

 

Enzymes

Image (chem structure or protein)

Velmanase alfa structure rendering